Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Change in Accured Expenses (2016 - 2025)

Skinvisible's Change in Accured Expenses history spans 16 years, with the latest figure at $75504.0 for Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 84.6% year-over-year to $75504.0; the TTM value through Sep 2025 reached $6543.0, down 99.2%, while the annual FY2024 figure was $420325.0, 8.07% up from the prior year.
  • Change in Accured Expenses for Q3 2025 was $75504.0 at Skinvisible, down from $121828.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $490421.0 in Q3 2024 and bottomed at -$291120.0 in Q4 2024.
  • The 5-year median for Change in Accured Expenses is $91006.0 (2022), against an average of $83565.0.
  • The largest annual shift saw Change in Accured Expenses soared 1479.14% in 2022 before it tumbled 363.82% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $5763.0 in 2021, then skyrocketed by 1479.14% to $91006.0 in 2022, then rose by 21.25% to $110349.0 in 2023, then crashed by 363.82% to -$291120.0 in 2024, then soared by 125.94% to $75504.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Change in Accured Expenses are $75504.0 (Q3 2025), $121828.0 (Q2 2025), and $100331.0 (Q1 2025).